Cargando…

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment

Detalles Bibliográficos
Autores principales:	Duan, Wanxing, Wang, Zheng, Qian, Weikun, Qi, Dan, Ma, Qingyong, Wu, Erxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260652/ https://www.ncbi.nlm.nih.gov/pubmed/35814423 http://dx.doi.org/10.3389/fonc.2022.923982

Ejemplares similares

NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer
por: Qin, Tao, et al.
Publicado: (2020)

High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer
por: Zhou, Cancan, et al.
Publicado: (2019)

Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
por: Sun, Hao-Ran, et al.
Publicado: (2019)

Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment
por: Chen, Yun-Wang, et al.
Publicado: (2022)

Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer
por: Li, Wei, et al.
Publicado: (2018)

Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
por: Zhou, Cancan, et al.
Publicado: (2018)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
por: Xu, Yiming, et al.
Publicado: (2023)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics
por: Pirini, Francesca, et al.
Publicado: (2022)

The prospect of tumor microenvironment-modulating therapeutical strategies
por: Eulberg, Dirk, et al.
Publicado: (2022)

Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling
por: Sun, Liankang, et al.
Publicado: (2018)

Editorial: Novel Targets and Targeting Technologies to Modulate Tumor Microenvironment
por: Prakash, Jai, et al.
Publicado: (2016)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Cancer prognosis: Considering tumor and its microenvironment as a whole
por: Qi, Dan, et al.
Publicado: (2019)

Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions
por: Chen, Xin, et al.
Publicado: (2021)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches
por: Singh, Manjari, et al.
Publicado: (2023)

The Tumor Microenvironment and Strategies to Improve Drug Distribution
por: Saggar, Jasdeep K., et al.
Publicado: (2013)

The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies
por: Wang, Danting, et al.
Publicado: (2022)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022)

Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)

Editorial: The effects of chemotherapy towards the tumor microenvironment
por: Abu, Nadiah, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis
por: Zhu, Zeen, et al.
Publicado: (2022)

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2022)

The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
por: Li, Ying, et al.
Publicado: (2021)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
por: Li, Ying, et al.
Publicado: (2023)

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
por: Behren, Andreas, et al.
Publicado: (2019)

Editorial: The tumor microenvironment and malignant properties in primary liver cancer
por: Qu, Chen
Publicado: (2023)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
por: Wobus, Manja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k44jf8pfek8a2s88p2tqotnfu3